Standout Papers

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 o... 2006 2026 2012 2019 1.7k
  1. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial (2010)
    M. William Audeh, James Carmichael et al. The Lancet
  2. Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer (2012)
    Jonathan A. Ledermann, Philipp Harter et al. New England Journal of Medicine
  3. Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial (2014)
    Jonathan A. Ledermann, Philipp Harter et al. The Lancet Oncology
  4. The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized (2006)
    Mark F. van Delft, Andrew H. Wei et al. Cancer Cell
  5. Target-enrichment strategies for next-generation sequencing (2010)
    Lira Mamanova, Alison J. Coffey et al. Nature Methods
  6. SOCS1 Is a Critical Inhibitor of Interferon γ Signaling and Prevents the Potentially Fatal Neonatal Actions of this Cytokine (1999)
    Warren S. Alexander, Robyn Starr et al. Cell
  7. Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial (2016)
    Jonathan A. Ledermann, Philipp Harter et al. The Lancet Oncology
  8. ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer (2020)
    Rowan Miller, Alexandra Léary et al. Annals of Oncology

Immediate Impact

16 by Nobel laureates 23 from Science/Nature 93 standout
Sub-graph 1 of 20

Citing Papers

Cell death
2024 Standout
In vivo hematopoietic stem cell modification by mRNA delivery
2023 StandoutScienceNobel
11 intermediate papers

Works of Clare L. Scott being referenced

Apoptosis-promoted tumorigenesis: γ-irradiation-induced thymic lymphomagenesis requires Puma-driven leukocyte death
2010
The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized
2006 Standout
and 10 more

Author Peers

Author Last Decade Papers Cites
Clare L. Scott 6532 6437 2555 175 13.0k
Cynthia C. Morton 2156 8600 1268 277 18.6k
Alan Ashworth 5625 9152 745 160 15.5k
Bruce A.J. Ponder 3492 8105 1105 176 15.5k
David Robertson 2116 7668 5180 358 18.0k
Martin Widschwendter 2102 7427 894 182 10.1k
Robert B. Jaffe 1323 4932 4259 293 13.9k
Susan K. Murphy 1555 6483 1088 261 12.0k
Luigi Frati 3421 6426 521 443 14.6k
Saadi Khochbin 2630 13868 840 198 16.3k
Fumihiko Matsuda 1018 4264 1791 338 13.1k

All Works

Loading papers...

Rankless by CCL
2026